Skip to main content
. Author manuscript; available in PMC: 2023 Jun 28.
Published in final edited form as: Toxicol Sci. 2022 Jun 28;188(1):88–107. doi: 10.1093/toxsci/kfac040

Table 2.

Top ten most sensitive gene set collections by median BMD for each chemical and cell type tested.

Chemical Name Most Sensitive Gene Sets (Pathways) Probe IDs Median BMD (MSigDB_C2), ppm Median BMDL (MSigDB_C2), ppm
Acrolein (BEAS-2B cells) REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF SQLE_6736;INSIG2_21088;CYP51A1_92320 0.585727 0.39902
NAKAMURA_ADIPOGENESIS_EARLY_DN SERPINE2_27841,SERPINE2_27842;PDE6D_13043;LOX_21772 0.746618 0.4431965
NAKAMURA_ADIPOGENESIS_LATE_DN SERPINE2_27841,SERPINE2_27842;PDE6D_13043;LOX_21772 0.746618 0.4431965
BIOCARTA_VDR_PATHWAY SMARCC2_12862;BAZ1B_17476;ARID1A_26387 0.746681 0.3875
REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN SMARCC2_12862;RUNX1_27815,RUNX1_6060;ARID1A_26387 0.746681 0.3875
LIU_COMMON_CANCER_GENES NDUFS8_4528;LIMD1_17670;ATP6V0A1_11775 0.752497 0.464197
ZHAN_MULTIPLE_MYELOMA_MS_DN OAS3_87750;MRPS31_92464;LETMD1_12057;DHPS_91625 0.760868 0.3744815
REACTOME_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION FN3K_92980;DPH2_91691;DHPS_91625;ARSJ_16411 0.7900935 0.343939
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP UGCG_11621;PLEC_14082;LRP8_13959;FLT3LG_25439 0.828844 0.397706
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR EXOC6_19851;DYNLRB1_15749;CHUK_1342 0.834914 0.360823
1-Bromopropane (BEAS-2B cells) GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP MAFF_27478,MAFF_28315;FTH1_92999,FTH1_93000;CD83_25945 2.24587 1.8379
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP RND3_24211;MAGOHB_22392;IER5_15403 2.25517 1.88619
SCHEIDEREIT_IKK_TARGETS NFKBIA_4568;NFKB1_4566;CYLD_17180 2.26819 1.85512
EPPERT_LSC_R TGIF2_27952;PPP1R10_16865;NAB1_13978 2.40606 1.98632
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP RELB_28340;NFKBIA_4568;MAFF_27478,MAFF_28315;EIF2AK3_24919;CNOT2_17056 2.45342 2.0422
BIOCARTA_DEATH_PATHWAY NFKBIA_4568;NFKB1_4566;BIRC3_11879 2.4806 2.06161
IKEDA_MIR133_TARGETS_UP NFAT5_16375,NFAT5_27581;MAFK_26036;CYLD_17180 2.48805 2.05714
ZHAN_MULTIPLE_MYELOMA_PR_DN JMJD1C_11504;FGF2_2405;CYLD_17180;ARID5B_88738,ARID5B_89998 2.50382 1.89154
KANG_CISPLATIN_RESISTANCE_UP TENT5A_15343;MAFF_27478,MAFF_28315;IER5_15403;FTH1_92999,FTH1_93000 2.5370175 1.7680525
PID_HIV_NEF_PATHWAY TRAF1_15516;NFKBIA_4568;NFKB1_4566;BIRC3_11879 2.579205 2.144825
1,3-Butadiene (BEAS-2B cells) TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN TM4SF1_12122;KDM6B_16198;HMOX1_3041 13.9794 7.78439
ABBUD_LIF_SIGNALING_1_UP SOCS3_15641;RGS4_20411;CEBPB_10745 21.3365 16.7624
CONRAD_STEM_CELL KLF5_20609;KLF4_23258;CXCL5_15735 26.4384 21.1357
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP PPP1R15A_14098;CEBPB_10745;ADM_12873,ADM_140 28.2428 20.7323
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP HMOX1_3041;CXCL8_14324;CEBPB_10745;BMP2_22143;ADM_12873,ADM_140 28.2428 20.7323
SEMENZA_HIF1_TARGETS HMOX1_3041;EDN1_2029;ADM_12873,ADM_140 28.2428 20.7323
ZAMORA_NOS2_TARGETS_UP IER2_3213;HMOX1_3041;ADM_12873,ADM_140 28.2428 20.7323
SWEET_KRAS_TARGETS_DN IRS2_21012;FOSL1_2463;DUSP4_1990;CXCL5_15735 28.5691 21.73905
HINATA_NFKB_TARGETS_KERATINOCYTE_DN RUNX1_20078;GPRC5A_15162;DUSP4_1990 29.0199 22.4869
AMIT_SERUM_RESPONSE_240_MCF10A TM4SF1_12122;PHLDA2_5123;ADRB2_151 29.6407 23.7457
Carbon Tetrachloride (BEAS-2B cells) ANDERSEN_CHOLANGIOCARCINOMA_CLASS1 TMEM156_25729;RGS4_20411;PTHLH_15144,PTHLH_5582;DCDC2_14713;CXCL6_15723 9.56328 7.98027
CAFFAREL_RESPONSE_TO_THC_UP ZFP36L1_14656;VEGFA_12596;MYC_4394;HIST1H2AC_93104;CPEB4_18785 11.2356 9.30456
MANN_RESPONSE_TO_AMIFOSTINE_UP ZFP36L1_14656;MYC_4394;GDF15_18329 11.2356 9.30456
CHIN_BREAST_CANCER_COPY_NUMBER_UP TGFB2_25683;PTGS2_5577;MYC_4394 11.6191 9.6667
DANG_MYC_TARGETS_DN ZFP36L1_14656;PDGFB_5026;MYC_4394;CDKN2B_14415 12.3503 10.23368
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN TGFB2_25683;PLAUR_23941,PLAUR_5179;NR3C1_4689 13.0934 10.60316
WALLACE_PROSTATE_CANCER_UP SOX4_6686;MYC_4394;GDF15_18329 13.347 9.58186
ZAMORA_NOS2_TARGETS_DN ZFP36L1_14656;SOX4_6686;SOX17_89363;NFIA_18923;HSPB8_15039 13.347 11.0524
PID_LKB1_PATHWAY TSC1_19318;SIK1_17023;MYC_4394 13.3507 9.14916
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN MYC_4394;ID1_14943;EREG_21427 13.3895 10.833
Trichloroethylene (BEAS-2B cells) ROVERSI_GLIOMA_LOH_REGIONS PPFIBP1_22884;NPFFR2_90111;GPRC5A_15162;DDHD1_10888 44.8416 29.00405
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER PPFIBP1_22884;MAL2_23815;CCN3_87436 47.0682 35.7006
OLSSON_E2F3_TARGETS_DN NFKBIA_4568;MAL2_23815;HIST1H1C_2950 65.4966 47.7346
VANASSE_BCL2_TARGETS_UP RELN_21362;MACC1_23235;HIST1H1C_2950 65.4966 41.4074
REACTOME_HDACS_DEACETYLATE_HISTONES HIST2H4B_16248;HIST2H4A_33956;HIST2H2BF_93215;HIST1H2BJ_92661;HIST1H2AG_93175;HIST1H2AC_93104 67.48565 54.3204
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER HIST1H1C_2950;GDF15_2621;DHRS2_1857 69.8154 60.8512
RADMACHER_AML_PROGNOSIS MAL_21284;FHL2_2423;EZR_25288;DAPK1_1752 72.244 51.08815
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP TENT5A_15343;OASL_89164;GPRC5A_15162;CCN3_87436 72.4401 49.10325
BASSO_HAIRY_CELL_LEUKEMIA_UP SUSD5_15755;MAF_13534;IGFBP3_3270;DAPK1_1752 72.6945 46.20455
AIYAR_COBRA1_TARGETS_DN ZNF532_20212;SOX4_6686;CLDN4_89537 73.9443 51.0529
Dichloromethane (BEAS-2B cells) REACTOME_DEPURINATION HIST2H4A_33956;HIST1H2BJ_92661;HIST1H2AC_93104 142.127 118.71
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN PPP1R15A_14098;HIST1H2BJ_92661;HIST1H2AG_93175 158.016 130.242
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN SQSTM1_6740;CHI3L1_14316;BHLHE40_689 160.996 132.484
BOYLAN_MULTIPLE_MYELOMA_C_DN KLF6_3626;JUN_89022;IRS2_21012 168.708 137.335
ZHAN_V2_LATE_DIFFERENTIATION_GENES NR3C1_4689;KLF6_3626;IRF1_21247 168.708 137.335
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER SMAD7_12470;IRS2_21012;HBEGF_15347,HBEGF_2892 191.462 159.963
REACTOME_EGFR_DOWNREGULATION SPRY1_18786;SH3KBP1_6296;HBEGF_15347,HBEGF_2892 191.462 159.963
REACTOME_SIGNALING_BY_EGFR SPRY1_18786;SH3KBP1_6296;HBEGF_15347,HBEGF_2892 191.462 159.963
PID_EPO_PATHWAY SOCS3_15641;NFKB1_4566;IRS2_21012 198.521 154.356
REACTOME_SIGNALING_BY_NON_RECEPTOR_TYROSINE_KINASES SOCS3_15641;NR3C1_4689;HBEGF_15347,HBEGF_2892 198.521 159.963
Trichloroethylene (pHBEC cells) KRIEG_HYPOXIA_VIA_KDM3A NRP2_27606;KDM3A_3541;EBP_2015 28.1584 15.5176
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION PCSK5_27656;NRP2_27606;LRBA_90214;AP1G1_21853 30.0328 16.13885
PID_VEGFR1_PATHWAY VEGFA_28053;NRP2_27606;CD2AP_13562 30.6881 16.3157
KEGG_N_GLYCAN_BIOSYNTHESIS MAN2A1_21283;MAN1A2_89683;MAN1A1_12471;ALG14_15409 30.87085 16.32435
REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS SGMS2_22813;SGMS1_13935;KDSR_14120 31.3726 16.5192
LUCAS_HNF4A_TARGETS_UP RBKS_5758;MAN1A1_12471;KIFAP3_22932;EBP_2015 32.1622 16.56735
YU_MYC_TARGETS_DN KLF2_16192;BTG1_26906;ABCA1_22891 32.2274 16.4188
REACTOME_FOXO_MEDIATED_TRANSCRIPTION SIRT1_21308;RBL2_5761;BTG1_26906;BCL2L11_26447 32.29735 16.61775
PID_FOXO_PATHWAY SIRT1_21308;SGK1_22771;RBL2_5761;BCL2L11_26447 32.48035 16.893
PID_HIF2PATHWAY VEGFA_28053;SLC2A1_14159;SIRT1_21308 32.5934 16.8167
Dichloromethane (pHBEC cells) MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS MAF_13534;KLF4_23258;IL6R_17769 266.73 204.336
DELACROIX_RAR_TARGETS_UP RESF1_15542;DUSP1_1978;BHLHE40_689 323.565 232.508
SWEET_KRAS_TARGETS_UP TPM1_28000;GADD45B_2570,GADD45B_28755;CLDN4_89537;BHLHE40_689;PGLS_16643 325.962 232.508
MENSE_HYPOXIA_UP PPP1R15A_14098;MAFF_27478,MAFF_28315;KLF4_23258;INSIG1_3385;ENO2_2153;BHLHE40_689 326.754 236.46375
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN TPM1_28000;IGF1R_3254;IER2_3213 329.401 236.301
NAKAMURA_ADIPOGENESIS_EARLY_DN TPM1_28000;IER2_3213;GDF15_18329 329.401 236.301
NAKAMURA_ADIPOGENESIS_LATE_DN TPM1_28000;IER2_3213;GDF15_18329 329.401 236.301
RASHI_RESPONSE_TO_IONIZING_RADIATION_1 IER2_3213;FOS_2461;DUSP1_1978 329.401 236.301
VANHARANTA_UTERINE_FIBROID_DN MAFF_27478,MAFF_28315;KLF4_23258;IER2_3213;GADD45B_2570,GADD45B_28755 329.672 238.36025
AMIT_DELAYED_EARLY_GENES MAFF_27478,MAFF_28315;FOSL1_2463;BHLHE40_689 329.943 240.4195